Clinical Trial Update: Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC) [NA]

View source ↗

Summary

A clinical trial evaluating bemotuzumab in combination with neoadjuvant chemotherapy for triple-negative breast cancer; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Bemotuzumab (bemotuzumab)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Triple-Negative Breast Cancer (TNBC), Neoadjuvant Chemotherapy | NA | Status: NOT_YET_RECRUITING